Rudolph E. Tanzi, PhD, Harvard University
Affiliations: | Neurology | Harvard Medical School, Boston, MA, United States |
Area:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=11Website:
http://www.mghmind.org/Faculty/tanzi_rudy.htmlGoogle:
"Rudolph Tanzi"Bio:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=11
Cross-listing: Neurotree
Children
Sign in to add traineeDoo Yeon Kim | grad student | (Neurotree) | |
Julien Muffat | grad student | Harvard Medical School (Neurotree) | |
Mehdi Jorfi | post-doc | (Neurotree) | |
Dora Kovacs | post-doc | Harvard Medical School | |
Joseph Park | post-doc | (Neurotree) | |
Wilma Wasco | post-doc | MGH/Harvard Medical | |
Ashley I. Bush | post-doc | 1992-1994 | Harvard Medical School |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Wittrahm R, Takalo M, Kuulasmaa T, et al. (2023) Protective Alzheimer's disease-associated APP A673T variant predominantly decreases sAPPβ levels in cerebrospinal fluid and 2D/3D cell culture models. Neurobiology of Disease. 106140 |
Chen XQ, Sawa M, Becker A, et al. (2023) Retromer proteins reduced in Down syndrome and the Dp16 model: impact of APP dose and preclinical studies of a γ-secretase modulator. Annals of Neurology |
Choi SH, Tanzi RE. (2023) Adult neurogenesis in Alzheimer's disease. Hippocampus |
Salta E, Lazarov O, Fitzsimons CP, et al. (2023) Adult hippocampal neurogenesis in Alzheimer's disease: A roadmap to clinical relevance. Cell Stem Cell. 30: 120-136 |
Jorfi M, Maaser-Hecker A, Tanzi RE. (2023) The neuroimmune axis of Alzheimer's disease. Genome Medicine. 15: 6 |
Hebisch M, Klostermeier S, Wolf K, et al. (2023) The Impact of the Cellular Environment and Aging on Modeling Alzheimer's Disease in 3D Cell Culture Models. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2205037 |
Bai P, Mondal P, Bagdasarian FA, et al. (2022) Development of a potential PET probe for HDAC6 imaging in Alzheimer's disease. Acta Pharmaceutica Sinica. B. 12: 3891-3904 |
Whitson HE, Colton C, El Khoury J, et al. (2022) Infection and inflammation: New perspectives on Alzheimer's disease. Brain, Behavior, & Immunity - Health. 22: 100462 |
Morgan SL, Naderi P, Koler K, et al. (2022) Most Pathways Can Be Related to the Pathogenesis of Alzheimer's Disease. Frontiers in Aging Neuroscience. 14: 846902 |
Liang Y, Lee DYW, Zhen S, et al. (2022) Natural medicine HLXL targets multiple pathways of amyloid-mediated neuroinflammation and immune response in treating alzheimer's disease. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology. 104: 154158 |